Alnughmush A, Sayyed A, Remberger M, Al-Shaibani E, Chen C, Chiarello C
Transplant Direct. 2025; 11(2):e1753.
PMID: 39802196
PMC: 11723673.
DOI: 10.1097/TXD.0000000000001753.
Stiehl T
Front Immunol. 2024; 15:1321336.
PMID: 39737169
PMC: 11682905.
DOI: 10.3389/fimmu.2024.1321336.
Konuma T, Kameda K, Morita K, Kondo T, Kimura F, Nakasone H
Am J Hematol. 2024; 100(1):66-77.
PMID: 39564683
PMC: 11625993.
DOI: 10.1002/ajh.27521.
Araki D, Chen V, Redekar N, Salisbury-Ruf C, Luo Y, Liu P
Cell Stem Cell. 2024; 32(1):53-70.e8.
PMID: 39536761
PMC: 11698648.
DOI: 10.1016/j.stem.2024.10.013.
Aydin Kaynar L, Ozkurt Z
Cureus. 2023; 15(9):e46105.
PMID: 37779681
PMC: 10534265.
DOI: 10.7759/cureus.46105.
Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma.
Ong K, Davis M, Purnell K, Cutshall H, Pal H, Connelly A
Front Oncol. 2023; 12:1074779.
PMID: 36733370
PMC: 9888259.
DOI: 10.3389/fonc.2022.1074779.
Synthetic pro-peptide design to enhance the secretion of heterologous proteins by Saccharomyces cerevisiae.
Cho J, Oh H, Jang Y, Kim H, Kim A, Song J
Microbiologyopen. 2022; 11(3):e1300.
PMID: 35765186
PMC: 9178654.
DOI: 10.1002/mbo3.1300.
Impact of G-CSF administration post-allogeneic hematopoietic stem-cell transplantation on outcomes: a systematic review and meta-analysis.
Gupta A, Meena J, Haldar P, Tanwar P, Seth R
Am J Blood Res. 2021; 11(5):544-563.
PMID: 34824887
PMC: 8610798.
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study.
George G, Martin A, Chhabra S, Eapen M
Biol Blood Marrow Transplant. 2020; 26(12):2359-2364.
PMID: 32818554
PMC: 7686090.
DOI: 10.1016/j.bbmt.2020.08.013.
A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies.
Rundgren I, Ersvaer E, Ahmed A, Ryningen A, Bruserud O
Medicina (Kaunas). 2020; 56(1).
PMID: 31963675
PMC: 7023283.
DOI: 10.3390/medicina56010036.
Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
Abdel-Azim H, Sun W, Wu L
Pharmacol Ther. 2019; 204:107403.
PMID: 31470030
PMC: 6881549.
DOI: 10.1016/j.pharmthera.2019.107403.
Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells.
Stokes J, Hoffman E, Molina M, Eremija J, Larmonier N, Zeng Y
Biol Blood Marrow Transplant. 2018; 25(3):405-416.
PMID: 30326280
PMC: 7571287.
DOI: 10.1016/j.bbmt.2018.10.009.
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product.
Halim L, Marquez M, Maas-Bakker R, Castaneda-Hernandez G, Jiskoot W, Schellekens H
Pharm Res. 2018; 35(11):226.
PMID: 30280277
PMC: 6182392.
DOI: 10.1007/s11095-018-2491-5.
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.
Garcia-Martinez E, Smith M, Buque A, Aranda F, Ayala de la Pena F, Ivars A
Oncoimmunology. 2018; 7(6):e1433982.
PMID: 29872569
PMC: 5980390.
DOI: 10.1080/2162402X.2018.1433982.
Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
Melve G, Ersvaer E, Eide G, Kristoffersen E, Bruserud O
Front Immunol. 2018; 9:845.
PMID: 29770133
PMC: 5941969.
DOI: 10.3389/fimmu.2018.00845.
Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation.
de Koning C, Gabelich J, Langenhorst J, Admiraal R, Kuball J, Boelens J
Blood Adv. 2018; 2(5):565-574.
PMID: 29535105
PMC: 5851423.
DOI: 10.1182/bloodadvances.2017015487.
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.
Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S
Int J Hematol. 2016; 104(6):709-719.
PMID: 27565504
DOI: 10.1007/s12185-016-2085-0.
Trial Watch-Immunostimulation with cytokines in cancer therapy.
Vacchelli E, Aranda F, Bloy N, Buque A, Cremer I, Eggermont A
Oncoimmunology. 2016; 5(2):e1115942.
PMID: 27057468
PMC: 4801437.
DOI: 10.1080/2162402X.2015.1115942.
G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept.
Deotare U, Al-Dawsari G, Couban S, Lipton J
Bone Marrow Transplant. 2015; 50(9):1150-6.
PMID: 25915812
DOI: 10.1038/bmt.2015.80.
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
Olsson R, Logan B, Chaudhury S, Zhu X, Akpek G, Bolwell B
Leukemia. 2015; 29(8):1754-62.
PMID: 25772027
PMC: 4527886.
DOI: 10.1038/leu.2015.75.